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24-Hour Blood Pressure Variability Assessed by Average Real
Variability: A Systematic Review and Meta-Analysis
Luis J. Mena, MSc, PhD; Vanessa G. Felix, MSc, PhD; Jesus D. Melgarejo, BSc; Gladys E. Maestre, MD, PhD
Background-—Although 24-hour blood pressure (BP) variability (BPV) is predictive of cardiovascular outcomes independent of
absolute BP levels, it is not regularly assessed in clinical practice. One possible limitation to routine BPV assessment is the lack
of standardized methods for accurately estimating 24-hour BPV. We conducted a systematic review to assess the predictive power
of reported BPV indexes to address appropriate quantification of 24-hour BPV, including the average real variability (ARV) index.
Methods and Results-—Studies chosen for review were those that presented data for 24-hour BPV in adults from meta-analysis,
longitudinal or cross-sectional design, and examined BPV in terms of the following issues: (1) methods used to calculate and
evaluate ARV; (2) assessment of 24-hour BPV determined using noninvasive ambulatory BP monitoring; (3) multivariate analysis
adjusted for covariates, including some measure of BP; (4) association of 24-hour BPV with subclinical organ damage; and (5) the
predictive value of 24-hour BPV on target organ damage and rate of cardiovascular events. Of the 19 assessed studies, 17 reported
significant associations between high ARV and the presence and progression of subclinical organ damage, as well as the incidence
of hard end points, such as cardiovascular events. In all these cases, ARV remained a significant independent predictor (P<0.05)
after adjustment for BP and other clinical factors. In addition, increased ARV in systolic BP was associated with risk of all
cardiovascular events (hazard ratio, 1.18; 95% confidence interval, 1.09–1.27). Only 2 cross-sectional studies did not find that high
ARV was a significant risk factor.
Conclusions-—Current evidence suggests that ARV index adds significant prognostic information to 24-hour ambulatory BP
monitoring and is a useful approach for studying the clinical value of BPV. ( J Am Heart Assoc. 2017;6:e006895. DOI: 10.1161/
JAHA.117.006895.)
Key Words: blood pressure variability • cardiovascular events • target organ damage
B lood pressure (BP) is a dynamic physiological parameter,influenced by behavioral, emotional, and environmental
factors, as well as intrinsic cardiovascular control. Daily
variation in BP is the sum of responses to extrinsic pressor
stimuli, spontaneous and regulatory fluctuations attributable
to influences of the central nervous system,1,2 mechanical
forces generated by respiration,3 and effects of humoral and
local vasomotor phenomena.4,5 Regardless of the causes,
arterial and cardiopulmonary reflexes act as modulators of
short-term changes in BP. Reduced efficacy of those reflexes
can result in significant increases in BP oscillations.6,7 Within-
subject BP variability (BPV) also increases with elevated
average BP and age.8,9 The clinical relevance of BPV during a
24-hour period was initially examined through intra-arterial
beat-to-beat measurements.9–11 Early studies showed that
increased BPV in hypertensive individuals is directly related to
severity of target organ damage.10–12 Later studies, using
noninvasive, intermittent, reading-to-reading, 24-hour ambu-
latory BP monitoring (ABPM), provided evidence that an initial
increase in BPV is an independent predictor of cardiovascular
events/complications.13–16 However, despite evidence of the
clinical relevance of BPV, its pathological role remains a
hypothesis, and it is not regularly used in clinical practice.
One possible limitation to routine BPV assessment is the lack
of standardized methods for accurately estimating 24-hour
BPV.17,18
The clinical significance and prognostic implications of
BPV depend on the measurement method6,19 and sampling
frequency.17–20 Most studies have evaluated the predictive
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value of BPV based on the SD of 24-hour average ABPM
recordings, but this index is an approximate indicator of BP
dynamics and does not capture many characteristics of
BPV.21–23 Because the SD is correlated with mean BP, it can
be inadequate to use both measurements in a multivariate
prognostic model.24 One solution is to use the coefficient of
variation (CV),25 which is the SD divided by the corresponding
mean; or to calculate the variation independent of mean,26
which is similar to the CV, but with the mean raised to a
power, x, that removes the correlation. Another important
limitation of the 24-hour SD is that its magnitude is
significantly affected by the nocturnal BP decrease in
individuals with large daily fluctuations.27,28 This “dipping”
phenomenon can reduce the prognostic power of 24-hour
SD.21 Calculation of a “weighted” 24-hour SD (wSD;
computed as the average of day and night SDs, weighted
for their respective durations) can minimize the effect of
nocturnal dipping without discarding information about
BPV.28,29
Hypertensive individuals are generally characterized by
steep, rapid, short-duration BPV that might have clinical
implications.30,31 However, the SD does not reflect the
steepness or rapidity. Therefore, the time rate of BP variation
(TRBPV) was proposed as an alternative index by Zakopoulos
et al.32 The TRBPV measures the steepness and speed of
changes in BP, calculated as the mean of the absolute ratios
of the difference between successive BP readings and the
time between them.
To improve the predictive power of 24-hour BPV, Mena
et al proposed the average real variability (ARV) index.33 This
method focuses on changes occurring over short time
intervals and, thus, corrects some of the limitations of SD,
which only reflects the dispersion of BP measurements
around the mean. The ARV index calculates the average of
absolute changes between consecutive BP readings:
ARV ¼ 1
N 1
XN1
k¼1
jBPkþ1  BPkj
where N denotes the number of valid BP measurements, and k
is the order of measurements. Mena et al33 concluded that
the ARV index has a greater predictive value than the SD and
is more useful for determining therapeutic measures aimed at
controlling BPV. However, the relatively high event rate
observed in that study indicated that its results could not be
completely extrapolated to the general population of hyper-
tensive subjects, and that further study of the prognostic
significance of the ARV index was required.21
This review systematically examines recent studies of the
ARV index and its prognostic value, specifically its association
with subclinical target organ damage and the incidence of
cardiovascular events in the general population and hyper-
tensive individuals. We critically discuss the methods that
should be considered for standardized estimation of 24-hour
BPV and other fundamental issues that need to be addressed
before this parameter becomes a regular tool for clinical use.
Methods
Only original publications in English language were consid-
ered. The quality of the relevant articles was assessed using
the guidelines recommended by Hayden et al.34
One author (V.G.F.) performed a literature search of
potentially relevant articles in the PubMed/MEDLINE database
using the keywords “ARV,” “average,” “real,” “blood pressure,”
and “variability” and in Google Scholar service based on
publications that cited Mena et al33 (up to July 2016). Two
authors (V.G.F., J.D.M.) reviewed the abstracts and titles to
identify relevant articles, and disagreements were resolved by
discussion and debate with a third author (L.J.M.). The full texts
of selected articles were obtained, and data were extracted,
verified, and checked independently by 2 authors (L.J.M.,
G.E.M.). Discrepancies were discussed to reach a consensus.
The studies chosen for review were those that presented
data for 24-hour BPV in adults from meta-analysis, longitu-
dinal or cross-sectional design, and examined BPV in terms of
the following issues: (1) method used to calculate and
evaluate ARV; (2) assessment of 24-hour BPV, determined
using noninvasive ABPM; (3) multivariate analysis adjusted for
covariates, including some measure of BP; (4) association of
Clinical Perspective
What Is New?
• Until now, there has not been a systematic review or meta-
analysis comparing the prognostic value of the different
indexes used to measure 24-hour blood pressure (BP)
variability.
• Average real variability was a better estimator of 24-hour BP
variability than other measures of dispersion. Average real
variability remained as an independent predictor after
adjustment for BP and other clinical factors for the presence
and progression of subclinical organ damage. Incidences of
cardiovascular events in the general population and hyper-
tensive individuals were considered.
What Are the Clinical Implications?
• The average real variability index adds significant prognostic
information to 24-hour ambulatory BP monitoring, and is a
useful approach for studying the clinical value of BP
variability. However, further investigation is required to
define potential diagnostic thresholds of abnormal BP
variability before this parameter becomes a regular tool
for clinical use.
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24-hour BPV with subclinical organ damage; and (5) the
predictive value of 24-hour BPV on target organ damage and
rate of cardiovascular events.
Data extracted from the reviewed studies included the type
of population, study design, sample size, sex distribution,
mean age, BPV indexes, confounding variables included in
multivariate analyses, and minimum number of valid BP
readings used to quantify BPV. For studies with several
multivariate analyses, we focused on fully adjusted models
that included BP as a predictor variable to avoid selection
bias. Only significant BPV predictors (P<0.05) were selected
to address independent risk contribution of BP variation over
and above the influence of elevated mean BP levels. When the
minimum number of 24-hour BP readings was not specified,
approximate values were estimated on the basis of sampling
interval and quality criteria defined by authors or assumed to
be 80% of the maximum possible BP measurements.
Data from long-term prognostic fatal and nonfatal cardio-
vascular events were pooled using a random-effects meta-
analysis. Only studies that provided hazard ratios were
included in this analysis. Heterogeneity was assessed using
the v2 test and I2 statistic.35 The Egger test36 was used to
assess the extent of publication bias. P<0.10 was considered
as heterogeneity and asymmetry between studies.
Results
The initial search identified 176 articles citing the article by
Mena et al (Figure 1).33 On the basis of our criteria, 157 were
excluded, leaving 19 articles in our systematic review. All
studies received ethical approval, and each participant gave
informed consent. Ten of these37–46 investigated the prog-
nostic value of 24-hour BPV (Table 1). Nine studies47–55
examined its relation to target organ damage (cardiac,
cerebral, arterial, renal, endothelial, and vascular).
The design of the 19 studies included 2 meta-ana-
lyses,37,38 3 prospective studies,39–41 and 14 cross-sectional
studies.42–55 Sample sizes ranged from 3652,54 to 893837
individuals, and the study populations included European,
Asian, and North American cohorts, as well as compounded
international databases. Eight studies focused on hyperten-
sive populations,40,42–45,48,49,55 and 3 of those included
patients with diabetes mellitus48 or chronic kidney dis-
ease.44,55 The remaining studies involved healthy sub-
jects,52,53 populations with mixed hypertensive
status,39,50,51,54 or subjects drawn from the general popula-
tion.37,38,41,46,47
Analytical approaches used by the 19 studies included mul-
tivariate analyses using Cox,37–40 logistic,41–46 or linear47–55
regression models, which incorporated ARV as an indepen-
dent variable. Six studies used ARV as a unique index for
estimating BPV.38,39,44,53–55 In addition to ARV, 10 studies
included measures of dispersion, such as SD,37,40–43,45–49
CV,41,42,46,47 and wSD.37,41–43,45–47 Three studies used alter-
native indexes, such as variation independent of mean50 or
TRBPV,51,52 to assess BPV. The estimated minimum number
of BP measurements required for accurate estimates of ARV
ranged from 1537 to 77.49 The mean of the minimum sampling
rate was of 42.916.7 BP readings. P<0.05 was considered
statistically significant in all cases.
176 articles identified through 
PubMed/MEDLINE and   
Google Scholar  
32 non-English 
articles excluded
144 articles 
screened
43 review articles 
excluded, based on 
abstract and title
101 full-text 
articles screened 
for eligibility 
 75 full-text articles 
excluded: no ARV 
calculation (26); not an 
outcome of interest (34); no 
24-h BPV (14); not an adult 
population (1) 
26 full-text 
articles assessed 
for eligibility 
19 articles 
included in the 
review 
 7 full-text articles excluded: 
only univariate analysis (5); 
multivariate analysis not 
adjusted for BP (1); 
duplicated study (1) 
Figure 1. Flow chart showing the process for selection of
articles. ARV indicates average real variability; BP, blood
pressure; and BPV, BP variability.
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Prognostic Significance of ARV
Four studies examined the long-term prognostic significance
of 24-hour BPV, estimated using ARV, for cardiovascular
outcome37–40 (Table 2). Two of the studies used large
samples from the International Database on Ambulatory
Blood Pressure in Relation to Cardiovascular Outcome and
combined results across cohorts in fully adjusted models.37,38
The results showed that ARV, SD, and wSD predicted
cardiovascular mortality over a median of 11.3 years of
follow-up.37 ARV and wSD predicted all fatal plus nonfatal
cardiovascular outcomes. ARV predicted fatal outcomes plus
nonfatal stroke. The authors concluded that ARV was a better
predictor than SD and wSD for most outcomes and, thus,
might be a more accurate measure of BPV than SD.37 A later
International Database on Ambulatory Blood Pressure in
Relation to Cardiovascular Outcome study that used a
minimum of 48 BP readings similarly found that ARV was a
significant and independent predictor of cardiovascular and
cardiac deaths and all cerebrovascular events.38
Hsu et al investigated the prognostic value of a high BPV in
normotensive and hypertensive subjects over a median
follow-up of 20 years.39 The results showed that ARV
predicted cardiovascular mortality independent of conven-
tional risk factors plus office BP. ARV was not a significant
predictor when 24-hour BP was included in the multivariable
models. However, in subgroup analysis, ARV significantly
predicted cardiovascular deaths in subjects with hyperten-
sion, independently of 24-hour mean BP and in addition to
well-known risk factors. The authors concluded that BPV
might be more useful than BP in long-term risk stratification
for untreated hypertensive subjects. Pierdomenico et al also
evaluated the independent prognostic significance of SD and
ARV as indexes of BPV in initially untreated and treated
hypertensive patients.40 Multivariate analysis adjusted for
other covariates, including BP, showed that ARV as either a
categorical or a continuous variable was an independent
predictor of cardiovascular events, whereas SD was not. The
authors concluded that ARV could be a more appropriate
index of BPV than SD and a more useful predictor of
outcomes.
Two studies evaluated the prognostic capacity of different
BPV parameters (SD, CV, wSD, and ARV) as risk factors for
cerebral small-vessel disease (CSVD), an important contrib-
utor to stroke and cognitive decline in elderly patients.56
Yamaguchi et al conducted a 4-year, community-based,
longitudinal study to determine whether CSVD progression
was independently related to BPV.41 Multivariable logistic
regression analysis using BPV as a continuous variable
showed that ARV and wSD were independent predictors of
CSVD progression after adjustment for confounding factors
and mean BP. The study also found that lacunar infarction was
significantly associated with cognitive impairment and that
only ARV differed significantly between subjects with and
without cognitive decline. Similarly, Filomena et al conducted
a cohort study on asymptomatic hypertensive patients to
evaluate the potential usefulness of BPV as a predictor of
CSVD, compared with BP and other clinical factors.42 Only
BPV, measured as ARV, was independently related to the
presence of CSVD. Furthermore, ARV was the only metric
significantly associated with lacunar brain infarcts and
periventricular and deep white matter hyperintensities.
Four cross-sectional studies examined the predictive
relationship of BPV to the development of organ damage.
Leoncini et al assessed the independent influence of BPV on
multiple target organ damage, including left ventricular
hypertrophy, carotid atheromatosis, and renal abnormali-
ties.43 High BPV, measured as SD, wSD, and ARV, was
associated with the simultaneous presence of 2 or more signs
of subclinical organ damage, regardless of several confound-
ing variables, including BP. Other multicenter studies of
patients with hypertensive chronic kidney disease showed
that ARV was an independent predictor of left ventricular
hypertrophy, after adjustment for 24-hour mean BP and other
factors.44 In a study of BPV as a predictor of renal
complications, multiple logistic regression analysis revealed
that the presence of microalbuminuria was independently
associated with ARV, after adjustment for average BP value
and other potential confounders.45 When ARV was replaced
by SD or wSD in the same model, BPV was not independently
associated with microalbuminuria. When the independent
correlates of urinary albumin excretion rate were explored
using stepwise linear multiple regression analysis, only ARV
was significantly related to the outcome variable. In contrast,
Madden et al found no significant correlations of BPV (SD, CV,
wSD, and ARV) with left ventricular hypertrophy in both
unadjusted and fully adjusted models. The association
Table 2. Multivariable-Adjusted Standardized HRs
Associated With Higher Systolic ARV as a Continuous Variable
Study
Cardiovascular
Outcome
No. of
Events
Median
Follow-Up,
y
Systolic ARV HR
(95% CI)
Hansen
et al37
Fatal and
nonfatal
1049 11.3 1.07 (1.00–1.48)*
Mena et al38 Fatal 335 10.2 1.17 (1.04–1.31)†
Hsu et al39 Fatal 90 20.0 1.20 (1.00–1.45)*
Pierdomenico
et al40
Fatal and
nonfatal
104 4.8 1.27 (1.06–1.51)*
Standardized HRs (95% CIs) were associated with a 1-SD increase in ARV for
cardiovascular events by fully adjusted Cox proportional hazards regression models. ARV
indicates average real variability; CI, confidence interval; and HR, hazard ratio.
*P<0.05, HR significance.
†P<0.01, HR significance.
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between BPV and microalbuminuria did not persist for all
indexes when mean BP was added to the model.46 However, a
subanalysis that included only subjects taking antihyperten-
sive treatment showed a significant association between ARV
and microalbuminuria, after adjustment for all confounders,
including mean BP. Table 3 shows odds ratios of studies that
determined that BPV assessed with ARV was an independent
predictor of organ damage.
Meta-Analysis
Figure 2 presents random-effects meta-analysis of hazard
ratios for increases in systolic ARV and all cardiovascular
events. Four studies that examined incidence of hard end
points show a significant association (hazard ratio, 1.18; 95%
confidence interval, 1.09–1.27; I2=0.0%; P=0.64). The Egger
test indicated no evidence of publication bias (P=0.95).
Association of ARV With Target Organ Damage
Nine studies evaluated the correlations between BPV and
target organ damage (Table 4). Two studies examined carotid
artery alteration, using carotid intima-media thickness as a
sign of early atherosclerosis. Xiong et al found that ARV
generally had a stronger relationship than SD or CV to intima-
media thickness.47 Comparison on the BPV parameters in a
mixed model with backward selection regression showed that
only ARV maintained a significant relationship to intima-media
thickness, which remained significant after adjustment for
baseline characteristics and mean BP. Wu et al concluded
that ARV had greater prognostic significance than SD for
evaluating the carotid intima-media thickness in hypertensive
patients with diabetes mellitus.48 Another study found that
ARV had the strongest relationship to arterial stiffness,
followed by the wSD and SD, after adjustment for age, sex,
and 24-hour BP.49 This result was confirmed through stepwise
multiple linear regression analysis, showing the relationship
between ARV and arterial stiffness was independent from, and
in addition to, office BP and average 24-hour BP. In contrast,
Wei et al found no significant association between BPV and 3
indexes of organ damage, except for an increase in aortic
pulse wave velocity with increasing variation independent of
mean and increasing difference between maximum and
minimum BP.50 However, the same study used the beat-to-
beat recordings method and found that the left ventricular
mass index was related to ARV, variation independent of
Table 3. ORs of Higher Systolic ARV for Progression of
Target OD
Study Outcome Measure Systolic ARV OR (95% CI)
Yamaguchi et al41 CSVD 2.05 (1.04–4.03)*
Filomena et al42 CSVD 1.16 (1.02–1.33)*
Leoncini et al43 Multiple OD 1.14 (1.00–1.29)*
Ryu et al44 LVH 1.05 (1.02–1.09)†
Mule et al45 MAU 5.34 (1.23–23.10)*
ORs (95% CIs) per 1–mm Hg increase in ARV by a fully adjusted multivariate logistic
regression model. ARV indicates average real variability; CI, confidence interval; CSVD,
cerebral small-vessel disease; LVH, left ventricular hypertrophy; MAU, microalbuminuria;
OD, organ damage; and OR, odds ratio.
*P<0.05, OR significance.
†P<0.01, OR significance.
0.5 1.0 1.5 2.0
Favours
increased
variability
Favours
decreased
variability
Hazard rao (95%)
Hansen et al.37 1.07 (1.00 – 1.48)
Mena et al.38 1.17 (1.04 – 1.31)
Hsu et al.39 1.20 (1.00 – 1.45)
Pierdomenico et al.40 1.27 (1.06 – 1.51)
Overall (I2=0%, P=0.64) 1.18 (1.09 – 1.27)
Figure 2. Random-effects meta-analysis of hazard ratios for increases of systolic average real variability
and all cardiovascular events.
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mean, and difference between maximum and minimum,
independently of BP and other covariables.
For renal damage, Diaz et al identified ARV and TRBPV as
independent determinants of renal function, positively
correlated with glomerular filtration rate in a multivariate
regression model that included age, body mass index, and
mean 24-hour BP.51 Later work by the same authors provided
evidence that BPV was higher in subjects with impaired
endothelial function and was associated with the vascular
smooth muscle response to nitric oxide.52 High ARV was also
significantly associated with a greater vasodilatory response
to nitroglycerin-mediated vasodilation53 and elevated levels of
high-sensitivity C-reactive protein,54 independent of mean BP.
High ARV was the strongest risk factor for endothelial
dysfunction in a study that evaluated the relationship between
various ambulatory BP parameters and flow-mediated dilata-
tion in kidney transplant recipients.55
Discussion
We conducted a systematic review to assess the predictive
power of various BPV indexes on target organ damage and
cardiovascular outcomes. Most studies found that ARV was a
better estimator of 24-hour BPV than other measures of
dispersion, including SD, CV, and wSD. Of the 19 assessed
studies, 17 reported significant associations between high ARV
and the presence and progression of subclinical organ
damage,41–45,47–49,51–55 as well as the incidence of hard end
points, such as cardiovascular events.37–40 For all these cases,
ARV remained an independent predictor after adjustment for
BP and other clinical factors. Moreover, in 11 of the 13 studies
that included several BPV indexes, ARV was the
best37,41,43,47,51,52 or unique40,42,45,48,49 significant predictor.
In addition, our meta-analysis showed that increased ARV in
systolic BP was associated with risk of all cardiovascular
events. Only 2 cross-sectional studies did not find that high ARV
was a significant risk factor. A study that computed ARV on the
basis of a low minimum number of BP measurements (<20
daytime and 7 nighttime BP readings) found no association with
preclinical organ damage.46 Another study found no associa-
tion between organ damage and 24-hour BPV, but did find a
significant association with beat-to-beat recordings.50
Despite extensive evidence that 24-hour BPV, particularly
ARV, provides superior predictive value than conventional BP
indexes (SD, CV, and wSD), the regular use of 24-hour BPV in
clinical practice remains problematic. Some studies have
found that the contribution of ARV to stratification risk,
although statistically significant, is low with for average BP
levels. For example, the International Database on Ambulatory
Blood Pressure in Relation to Cardiovascular Outcome reports
indicated that the incremental risk explained by adding ARV to
models that included 24-hour ambulatory BP and other
covariables was only 0.1%.37,38 However, these results might
have been influenced by different methods of 24-hour ABPM
used in the different cohort studies whose data were pooled
in the analysis.6,57
On the other hand, heterogeneity in the metrics and
protocols used in different studies is an overall problem in
evaluating the predictive value of BPV.17,58 Therefore, several
methodological problems need to be addressed before BPV is
routinely used in clinical practice. An important constraint is
that the discontinuous nature of noninvasive ABPM devices
might limit its accuracy in assessing rapid changes in BP.19,59
Identification of an optimal measurement interval is key to the
reliable estimation of the beat-by-beat oscillations that occur
in seconds. Di Rienzo et al20 demonstrated that quantification
of SD using a time interval >15 minutes increases the
potential error in estimating the true variance. However, short
sampling intervals are rarely used in clinical settings, for
practical reasons and because of the potential discomfort of
patients.21 The influence of the measurement interval gives
the use of ARV an advantage over alternative approaches,
such as TRBPV, which is potentially more sensitive to the
sampling rate.22
Another methodological problem is that the minimum
number of valid BP measurements needed to provide a
reproducible and reliable assessment of BPV might not have
been reached in all studies that use ARV. Mena et al
concluded that 48 BP readings during a 24-hour period is
sufficient to compute ARV without meaningful loss of
prognostic information.39 In fact, ARV might be less sensitive
to missing readings and low sampling frequency than other
BPV indexes. Eguchi et al60 tested the reproducibility of ARV,
SD, and wSD in hypertensive patients, before and after
antihypertensive treatment. ARV exhibited the greatest
reproducibility during both the observation and treatment
periods. In agreement with those results, ARV was a
significant predictor in 10 of the 11 studies with a minimum
number of BP readings below the average lowest sampling
rate.37,39,41,44,47,48,51–54
Although ARV has been shown to be a better predictor of
risk than SD for most adverse outcomes,37,40–42,48,49 studies
to date have not estimated ARV using real-time monitoring,
because no existing ABPM devices incorporate automatic
quantification of ARV or other novel BPV indexes. The
procedures for collection, computation, and storage of
electronic BP recordings need to automatically provide
accurate calculations of 24-hour BPV.
In conclusion, the current evidence suggests that the ARV
index adds significant prognostic information to 24-hour
ABPM, and is a useful approach for studying the clinical value
of BPV. Moreover, technical features of ARV could resolve
some methodological problems: ARV (1) is simple to compute,
(2) is relatively insensitive to low sampling frequency, (3) is
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not strongly influenced by cyclic components, (4) is sensitive
to the sequential order of BP readings, and (5) provides insight
into BP changes. However, even if ARV is accepted as the
optimal index for reliable and reproducible evaluation of
24-hour BPV, methodological standardization is only an initial
step for incorporating it in clinical practice. Further investi-
gation is required to define potential diagnostic thresholds of
abnormal BPV, to determine if reduction below those
thresholds is associated with a decrease in target organ
damage and/or risk of cardiovascular disease, to identify
treatments that reduce BPV, and to clarify whether those
therapeutic interventions provide additional prognostic bene-
fit, independent of a reduction in mean BP.
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